192 results
6-K
EX-99.1
IPHA
Innate Pharma
7 May 24
Innate Pharma announces conference call and webcast for Q1 2024 business update
6:03am
statements, including those within the meaning of the Private Securities Litigation Reform Act of 1995. The use of certain words, including “believe
6-K
EX-99.1
IPHA
Innate Pharma
15 Apr 24
Innate Pharma Announces Advancement Of Sanofi-Developed Nk Cell Engager Sar443579 / Iph6101 Progressing To Phase 2 For Blood Cancer Patients
6:02am
forward-looking statements, including those within the meaning of the Private Securities Litigation Reform Act of 1995. The use of certain words
6-K
EX-99.1
IPHA
Innate Pharma
15 Apr 24
Current report (foreign)
6:00am
the meaning of the Private Securities Litigation Reform Act of 1995. The use of certain words, including “believe,” “potential,” “expect
6-K
EX-99.1
IPHA
Innate Pharma
10 Apr 24
Innate Pharma Presents at AACR 2024 Preclinical Efficacy of its Pre-IND Drug Candidate IPH45, a Novel Nectin-4 Antibody Drug Conjugate
6:51am
-looking statements, including those within the meaning of the Private Securities Litigation Reform Act of 1995. The use of certain words, including
6-K
EX-99.1
qjueqn 4qvpqhmc8z
21 Mar 24
Innate Pharma reports Full Year 2023 Financial Results and Business Update
6:01am
6-K
EX-99.1
aaglx
19 Mar 24
Innate Pharma Announces Its Participation To Upcoming Investor Conference
6:33am
6-K
EX-99.1
4s1sjud7vkgemy 6i
14 Mar 24
Innate Pharma Announces Conference Call And Webcast For Full Year 2023 Financial Results
7:00am
6-K
EX-99.01
1npwj4gdb2y9a8lvqs
6 Mar 24
Current report (foreign)
6:00am
6-K
EX-99.01
z1ekzat
6 Mar 24
Current report (foreign)
6:00am
6-K
EX-99.1
w7yw3w
21 Feb 24
Innate Pharma Announces Its Participation To Upcoming Investor Conference
6:00am
6-K
EX-1.1
8l0h36ssou8vpa1
6 Feb 24
Current report (foreign)
5:05pm
424B5
wmu3iz1gzxmv8
6 Feb 24
Prospectus supplement for primary offering
5:00pm
6-K
EX-99.1
mqxf1
12 Jan 24
Innate Pharma S.a. 6-K
6:00am
6-K
EX-99.1
i0e3gk3
4 Jan 24
FDA lifts partial clinical hold on lacutamab clinical programFatal case related to disease progression and unrelated to the treatment
6:01am
6-K
EX-99.1
k8561v40q8w2w
4 Jan 24
Innate Pharma 6-K
6:00am
F-3
wy6gyq 01m2c
20 Dec 23
Shelf registration (foreign)
4:45pm
6-K
EX-99.1
mxghzkh abd8474ypi1s
19 Dec 23
Innate Pharma S.a. 6-K
6:00am
6-K
EX-99.1
zik940vw
18 Dec 23
Innate Pharma S.a. 6-K
11:40am